Similar results were present in the case of the ERBB2 gene, which encodes a cell surface protein-tyrosine kinase receptor that is associated with the progression of breast cancer 20 and higher expression of genes in the Wnt-β-catenin pathway. Here, ERBB2 is linked to breast carcinoma.